Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
about
Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles PerspectiveRedox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequencesReactive oxygen species and fibrosis: further evidence of a significant liaisonNrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitisMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseChronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult MiceNrf2 enhances cholangiocyte expansion in Pten-deficient liversHigh Fat Diet-Induced Hepatic 18-Carbon Fatty Acids Accumulation Up-Regulates CYP2A5/CYP2A6 via NF-E2-Related Factor 2.Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver.NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1β genesNrf2 affects the efficiency of mitochondrial fatty acid oxidation.Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in miceButyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation.Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease.Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome.Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.Role of the Nrf2-ARE pathway in liver diseasesNrf2: a potential target for new therapeutics in liver disease.Drug metabolism alterations in nonalcoholic fatty liver diseaseNrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat dietNew insights from rodent models of fatty liver diseaseFatty acids and the endoplasmic reticulum in nonalcoholic fatty liver diseaseNuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis.Role of Nrf2 in chronic liver disease.OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease.The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.NADPH Oxidases in Chronic Liver Diseasesp62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.Naturally Occurring Nrf2 Activators: Potential in Treatment of Liver Injury.Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling PathwayRosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice.Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH.Non-Alcoholic Fatty Liver Disease.Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2.
P2860
Q26770805-6CF09649-97F2-40F8-A625-EA58A7180926Q26786129-D2842D7D-E6AA-4D07-B391-C327F55D76F2Q28077930-9E4A418C-8620-4E66-83B6-8E878BB37789Q28392304-67A53120-27F1-447C-840A-43E72D00F376Q28394732-DFE73E6D-582A-434C-9116-468CF505B687Q32186681-BDC42114-B0C7-474D-BBBD-09E0DBA27C87Q33623150-89A83AFF-57A7-454C-8F1D-6232130BD86FQ33683799-9B02BCD6-5268-4D62-8125-75B5B2E682F2Q33939951-FAA0FEB8-4EE4-4C51-948F-EED79A0E255DQ34274999-7F252896-7D3A-462E-811D-AA91D7E0BAE1Q34398472-C6778611-7BD2-4E18-B77F-9B823C355C6CQ34605967-760CAECF-E8BF-4EC8-BC87-F073AE05BE59Q34733841-BB60A21A-9DAE-4AC4-9E43-1D1C9A2278A4Q34974831-F4E59F7E-B225-4A20-A1E4-E070A6607559Q35055531-787876FF-2ACE-4DED-AC45-E5D8EEE72F43Q35815261-04018FCB-01F2-4CCB-8443-EBE6334006CDQ35993987-0DACB18A-073C-4DF4-983B-F02618E16D66Q36695768-A8C2E442-E007-4A83-9873-CF35D1B2B2CDQ36788693-C081FBCF-5A71-47D8-A469-57160743D2B9Q36879950-85E6DA95-E390-470A-B080-27195C38ABD8Q36991534-B9237F44-B26D-46AE-B3F5-B93570A2A905Q37120909-1F87772A-4466-43F5-B9B8-3E5D7AAB713EQ37305784-431CE662-5884-49F2-9AA3-9C216A3EA372Q37815214-C26E43BF-AF2F-41BD-90A5-9B2F0A72B571Q37844020-B7264623-ABC1-434C-A2B3-BA7D2CFF4220Q38087926-8F2F6EFA-8594-4644-A44C-226D0029F59AQ38256342-6C1FCFFD-D65A-4B31-B4EF-1CC0FC3BD8FDQ38421096-A3BB1EA9-C728-4500-A46F-5E94B0C17AE0Q38539752-32370BAF-D7E2-454D-8718-2B13BBC3E618Q38569922-A26C3C21-80AF-4AE3-8B10-00ABBC1C8EABQ38599090-C23D1421-99CA-4A53-BD4C-5BE3794755BEQ38893853-1C9C9A79-9E7E-4B8B-BBB9-ADAB0F670283Q38895458-5BAF7366-904C-428F-9091-39D1A96D4C22Q39094306-480D2410-3B8E-4E8A-A1D0-AC7FA9DE9D7EQ41432002-C85B66D4-7DAA-4E86-901C-850AF5F54713Q41527515-FE5753D3-1DD9-4FEE-A76F-6D9C5D998E11Q42416040-9BB68E58-497C-4319-941C-E4740DDC55ACQ47584564-79ECA995-5214-42AD-AD75-A0B28E43900FQ50957769-567203F2-9C63-4D22-BACD-6CE25255C8B5Q51095047-8FD94BC9-AEAF-4A98-88E6-59BE2EBD232E
P2860
Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Deletion of nuclear factor-E2- ...... ional steatohepatitis in mice.
@en
Deletion of nuclear factor-E2- ...... ional steatohepatitis in mice.
@nl
type
label
Deletion of nuclear factor-E2- ...... ional steatohepatitis in mice.
@en
Deletion of nuclear factor-E2- ...... ional steatohepatitis in mice.
@nl
prefLabel
Deletion of nuclear factor-E2- ...... ional steatohepatitis in mice.
@en
Deletion of nuclear factor-E2- ...... ional steatohepatitis in mice.
@nl
P2093
P2860
P356
P1476
Deletion of nuclear factor-E2- ...... ional steatohepatitis in mice.
@en
P2093
Akira Nakahara
Eiji Warabi
Hirokazu Sugimoto
Ichinosuke Hyodo
Junichi Shoda
Kazunori Ishige
Keiko Taguchi
Kosuke Okada
Masayuki Yamamoto
Tetsuro Ishii
P2860
P304
P356
10.1152/AJPGI.00296.2009
P577
2009-11-19T00:00:00Z